During the past decade, Analgesic Solutions conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Analgesic Solutions" #1 collaborator was "Forest Laboratories" with 1 trials as a collaborator, "Grünenthal GmbH" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Analgesic Solutions" are "Osteoarthritis, Knee" (2 trials), "Herpes Zoster" (1 trials), "Neuralgia" (1 trials), "Osteoarthritis" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Analgesic Solutions" in a lesser frequency.

Most popular intervention types in "Analgesic Solutions" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BMS-954561" (1 trials), "C" (1 trials), "Drug Placebo Administration" (1 trials) and "EPT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Analgesic Solutions" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Analgesic Solutions". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Analgesic Solutions, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Analgesic Solutions, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".